ESMO - Eur. Oncology
@myESMO
Followers
81K
Following
31K
Media
6K
Statuses
20K
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
Lugano - Switzerland
Joined August 2009
#ESMOImmuno25 Awardee, @DrIgMelero, discusses how current #immunotherapy can be improved upon with the use of synergistic approaches including combination therapies and targeting resistance mechanisms. Full interview in the #ESMODailyReporter ➡️ https://t.co/n48zARH4qh
0
0
1
📣 #ESMOImmuno25: A. Marabelle, I.M. Svane and S. Quezada welcome you to the ESMO Immuno-Oncology Congress 2025, an international event to explore the science driving the next generation of cancer care. #esmomeetings 🔗 https://t.co/P27qku2bdW
0
1
5
🌍 Uniting the Asia-Pacific oncology community! ESMO Asia 2025: 4,550+ participants, 170+ speakers, 71 sessions & 940+ abstracts shared. 🙌 A record-breaking milestone for oncology in Asia! #ESMOAsia25 #esmomeetings 🔗 https://t.co/ipOjagiH5t
0
5
14
🆕article in press: Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer (DUO-O) https://t.co/A0CUDkQUC5
0
15
48
ESMO supported the development of the @IARCWHO Teaching Toolkit on identifying carcinogenic hazards to humans. The third module of the series is now available via the IARC Learning space on the WHO Academy.
Are you involved in teaching evidence-based cancer prevention to different categories of professionals? This new teaching toolkit on Identification of Carcinogenic Hazards to Humans! https://t.co/UsgyZ8vszT
@myESMO
0
0
5
Join this global community of @myESMO which is across oncology worldwide, including huge opportunities for #YoungOncologists
#ESMOAsia25
#ESMOYOC
#ESMOMembership
Consider joining @esmo as a member at #ESMOAsia25 with this amazing deal and be part of a 50k strong membership family! @myESMO
1
2
11
(my) Conclusions in a challenging topic #IntermediateStage #HCC The key is probably to select the best approach for each patient (MDT) When TACE alone? When TACE+Systemic? When Systemic alone? Nice discussion @myESMO #ESMOAsia25 I agree with your conclusions @LorenzaRimassa
0
6
18
#ESMOAsia25: Studies in cancer of unknown primary (#CUP) highlight the need to perform routine comprehensive #GenomicProfiling and then provide access to the appropriate #TargetedTherapy. Find out more in the #ESMODailyReporter ➡️ https://t.co/5HEZ4mTxVu
0
6
19
#ESMOAsia25: #ClinicalTrials investigated antibody–drug conjugates (#ADCs) with payloads other than topoisomerase I inhibitors and targets beyond HER2 in attempts to minimise cross-resistance. Read more in the #ESMODailyReporter ➡️ https://t.co/CFSrjdjC5l
@PTarantinoMD
0
10
23
0
12
38
@myESMO #HCC CPG and PAGA: more similarities than differences #ESMOAsia25 @ArndtVogel @LizzySmyth1 #ChihKiangTan
0
1
12
Session on radiotheranostics at @myESMO #ESMOAsia25 Chaired by #ElenaGarralda 💡PET Tumor Volume 💡SUV max 💡SUV mean 👉Dosimetry: pre-treatment and post-treatment 👉Selection of emitter and bystander effect 👀Long-term toxicity
2
3
9
0
3
12
Thank you @myESMO #ESMOAsia25 for inviting me to review the current @myESMO Guidelines in #PancreaticCancer 📝Western vs PAGA version It’s crucial to adjust recommendations to each part of the world. Reality varies even within the same country. #ESMOGuidelines
2
5
26
#ESMOAsia25: Impressive results from the Chinese LUMINET-1 phase III trial confirm and extend previous findings with 177Lu-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours (#GEP-NETs). Read more in the #ESMODailyReporter ➡️ https://t.co/5N7CAK9XA8
0
6
11
Josephine Contreras-Tolentino discusses why acknowledging population diversity matters. As shown at #ESMOAsia25, ethnicity differences can impact on presentation and tolerability, which can influence treatment selection. Read more: https://t.co/oaNS3dOlyd
#ESMODailyReporter
1
4
8
@ModestDominik discusses precision medicine in #colorectal cancer treatment at #ESMOAsia25 @myESMO @LizzySmyth1
0
3
6